In a study of the breast cancer population (Knüpfer and Preiss, 2007), IL-6, as a key inflammatory factor, plays an important role in promoting tumor progression, and high circulating levels of IL-6 and age are associated with poor prognosis in breast cancer patients. This evidence concerns the gene IL6 and breast carcinoma.